ABSTRACT
Objective@#To investigate the immune enhancement effect of red ginseng aqueous extract in mice.@*Methods@#The aqueous extract of red ginseng was obtained by water extraction and concentration, and the aqueous extract 10 ml was equivalent to raw material 2.86 g. The experiment was divided into the blank control group, low dose group of red ginseng aqueous extract 0.24 g/(kg•d), middle dose group 0.48 g/(kg•d) and high dose group 1.43 g/(kg•d). In order to explore the immunoregulation effect of red ginseng aqueous extract, Organ/body weight ratio measurement, the delayed type hypersensitivity (DTH) reaction, the spleen lymphocyte transformation experiment induced by Con A, the detection of antibody-producing, the determination of serum hemolysin experiments, the clearance rate of carbon particles, the phagocytosis effect of macrophages with chicken red blood cell experiments, and the determination of natural killer cell activity were carried out with the mice.@*Results@#Compared to the blank control group, the tow edema degree (0.62 ± 0.14 mm, 0.53 ± 0.12 mm vs. 0.36 ± 0.10 mm) of low dose group and medium dose group significantly increased (P<0.05). The ability of proliferation of T lymphocytes (0.173 ± 0.054, 0.189 ± 0.063 vs. 0.098 ± 0.012) of low dose group and high dose group significantly increased (P<0.05). The number of haemolytic empty spots (137.49×103 ± 24.73×103, 148.43×103 ± 27.53×103 vs. 112.96×103 ± 26.28×103) of medium dose group and high dose group significantly increased (P<0.05). The phagocytosis rate (35.67% ± 3.82%, 49.26% ± 6.54%, 57.92% ± 7.36% vs. 24.34% ± 4.22%) and index (0.72 ± 0.23, 0.82 ± 0.15, 0.91 ± 0.26 vs. 0.35 ± 0.11) of low-, medium-, high-dose group significantly increased (P<0.05). However, there was no statistical difference in the organ/body weight ratio of the experimental animals, the determination of serum hemolysin experiments, the clearance rate of carbon particles, and NK cells activity.@*Conclusion@#Red ginseng aqueous extract has an exact role in immunity improvement in mice.
ABSTRACT
The renin-angiotensin system exists locally in bone tissue.The RAS components and the active peptide angiotensinⅡ (Ang Ⅱ)within RAS are directly involved in the pathophysi-ological process of regulating bone metabolism.Ang Ⅱ exerts the effects via its receptors expressed in osteoblasts and osteoclasts. This paper reviewed the pathways of classical RAS,explained the tissue RAS-induced tissue injuries,and especially elaborated the regulation of RAS active peptide Ang Ⅱ on target genes and in-tracellular signaling pathways in osteoblasts,the action of Ang Ⅱon osteoclastic function via acting on osteoblasts,and the inter-action of Ang Ⅱ receptors involved in the modulation on bone metabolism.
ABSTRACT
Objective To investigate the role of insulin resistance in patients with prostate cancer who received surgical castration. Methods Sixty-seven patients with advanced prostate cancer who received with surgical castration were divided into obesity group [30 cases, BMI (26.85±1.22) kg/m2] and non-obesity group[37 cases, BMI(22.72±1.28) kg/m2]. The fasting blood glucose (FBG) and the fasting serum insulin, while evaluated the insulin resistance index(IRI) were determined before treatment, 6 months after treatment and 12 months after treatment. Results The levels of fasting serum insulin were significantly higher 6 months[(23.21±5.78 )mU/L] and 12 months [(24.34±5.37) mU/L] after treatment than that be-fore treatment[(20.01±4.82) mU/L] in obesity group, but 12 months after treatment [(22.19±6.14) mU/L ]was higher than that before treatment [(17.36±6.01) mU/L] in non-obesity group (P<0.01). The IRI were significantly higher 6 months (2.94±0.79) and 12 months (3.10±0.73) after treatment than that be-fore treatment (2.53±0.64) in obesity group, but 12 months after treatment (2.79±0.75) was higher than that before treatmeat(2.17±0.73) in non-obesity group(P<0.01). Conclusion The current data suggests that the patients with prostate cancer who received surgical castration is at risk for developing insulin resistance, thus leading to increasing risk of cardiovascular disease and type 2 diabetes mellitus.
ABSTRACT
Objective To investigate the quality of life in man after treatment of advanced prostate cancer by surgical castration. Methods A total of 69 patients with advanced prostate cancer treated by sur-gical castration completed the European organization for research and treatment of cancer quality of life questionnaire (QLQ-C30) and QLQ-prostate specific 25-item (PR25) module third at a 12-month interval.The assessment points were preoporative,6 months postoperative and 12 months postoperative. Results Although there were improvement on pain relief (P ＜ 0.01 ) and symptom of urinary (P ＜ 0.01 ) and global health (P ＜ 0.01 ), the physical functioning (P ＜ 0.05 ), role functioning (P ＜ 0.01 ), emotional functioning (P ＜ 0.01 ), cognitive functioning (P ＜ 0.05 ), social functioning (P ＜ 0.05 or ＜ 0.01 ) were found significantly reduced , and insomnia (P ＜ 0.05) and fatigue (P ＜ 0.01 ) aggravated, treatment related symptoms (P ＜0.01 )appeared predominantly, especially deprivation of sexual functioning. Conclusion The surgical cas-tration when treating advanced prostate cancer did appear to impair the physical and psychological of patients, especially the sexual functioning.